Spark Therapeutics, Inc. (ONCE) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 08/07/2019 1 month $101.79 $100.57 -1.2% 1 Active
Comments: Zombie stock. Slow market. High Risk. Stock overvalued
Chrisyahahha Chrisyahahha 01/04/2016 3 months $41.52 +142.25% 0 Ended
brainchild87 brainchild87 10/10/2015 3 months $49.30 $34.30 -30.43% -30 Ended
uws2013ny uws2013ny 03/20/2015 1 week $71.90 $65.77 -8.53% -8 Ended
Comments: Pioneering gene therapy for inherited eye disorders & Pfizer

Neither NASDAQ, Inc. nor any of its affiliates (collectively "NASDAQ") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ. Investors should undertake their own due diligence and carefully evaluate companies before investing.